ArticleExploration of drug science2025

Experimental and clinical tests of FDA-approved kinase inhibitors for the treatment of neurological disorders (update 2024).

Hassan Aliashrafzadeh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.